share_log

Jefferies Initiates Coverage On ProKidney With Buy Rating, Announces Price Target of $15

Jefferies Initiates Coverage On ProKidney With Buy Rating, Announces Price Target of $15

杰富瑞开始以买入评级对ProKidny进行报道,宣布目标价为15美元
Benzinga Real-time News ·  2022/12/21 06:21

Jefferies analyst Kelly Shi initiates coverage on ProKidney (NASDAQ:PROK) with a Buy rating and announces Price Target of $15.

杰富瑞分析师Kelly Shih对ProKidney(纳斯达克代码:PROK)的报道给予买入评级,并宣布目标价为15美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发